Immunoradiometric assay of CA 125 in effusions comparison with carcinoembryonic antigen
- 15 January 1987
Abstract
The levels of CA 125 antigen were measured in 167 effusions from 150 patients using radioimmunoassay, and the results compared with the levels of carcinoembryonic antigen (CEA) in the fluids. This study was carried out to test a hypothesis that measuring the combined levels of selected tumor associated antigens in effusions could predict the primary source of malignancy. The results indicate that an elevated fluid CA 125 level (>14,000 U/ml-68,000 U/ml) and a negative fluid CEA level (Cancer 59:218–222, 1987.This publication has 11 references indexed in Scilit:
- Immunopathologic Analysis of a Panel of Mouse Monoclonal Antibodies Reacting with Human Ovarian Carcinomas and Other Human TumorsInternational Journal of Gynecological Pathology, 1985
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- CA125-ANTIGEN LEVELS IN OBSTETRIC AND GYNECOLOGIC PATIENTS1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Diagnostic Value of Carcinoembryonic Antigen in Exudative Pleural EffusionsChest, 1980